2020 annual financial data
Corcept Therapeutics 2020 Operating margin
Direct answer
Operating margin was 36.23%.
Operating income was 128,202,000 USD and net income was 106,011,000 USD.
Operating cash flow was 151,970,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 353,874,000 USD
- Operating income
- 128,202,000 USD
- Net income
- 106,011,000 USD
- Operating cash flow
- 151,970,000 USD